Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation
Cystic Fibrosis Foundation to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating... | March 29, 2022